“The new paths of psychiatry” in WDR

The Westdeutscher Rundfunk (WDR) on October 8th and 9th, 2017, broadcasted an interesting feature on the “new paths of psychiatry”, which contains many statements I made during an interview on the future of psychopharmacology.

Cariprazine: the next touchstone for the German AMNOG

The interesting new antipsychotic compound cariprazine was recently approved by the European Medicines Agency (EMA). Its launch in Germany will be a new touchstone for the German Act on the Reform of the Market for Medicinal Products (AMNOG).

Therapeutic Drug Monitoring in Neuropsychopharmacology

The new “Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017” were just published.